Navigation Links
BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure
Date:10/14/2010

ARLINGTON, Va., Oct. 14 /PRNewswire/ --  BioInformatics, LLC announces the pending release of three Q4 market reports:

RNAi:  Product Usage & Brand Assessment (#10-006)Exploring Structural Biology:  Tools & Techniques Used in the Study of Membrane Protein Structure (#10-004)Genomic Technologies:  Market Insights for Life Science Suppliers (#10-005)In an effort to support suppliers who provide product and services to these three rapidly growing markets, BioInformatics is publishing three titles in the fourth quarter of 2010.  Given the accelerated changes in each of these technologies, these three reports provide suppliers up-to-date primary research that identifies trends, planned expenditures and anticipated growth.

RNAi:  Product Usage & Brand Assessment (#10-006)Scheduled for release on October 15, 2010, this report will provide market insights and analysis to suppliers of products and services that support RNAi experiments. By using this report, RNAi product suppliers will gain an understanding of where scientists predict the future of RNAi technologies is headed so as to better anticipate current and upcoming RNAi product needs.

In this report, scientists indicate planned instrument and consumable purchases by vendor.  The following suppliers were provided as some of the choices in the survey:

Abnova

Affymetrix (NASDAQ: AFFX)

Agilent Technologies (NYSE: A)

Ambion

B-Bridge

Bioneer

Biosettia

Bio-Rad (NYSE: BIO)

Cellecta

Cell Signaling Technology

Clontech

Dharmacon

EMD Millipore

Eurofins MWG Operon

Exiqon

GeneCopoeia

Genosensor

Hamilton Life Science Robotics

Imgenex

ImaGenes

Integrated DNA Technologies

InvivoGen

LC Sciences

Life Technologies (NasdaqGS: LIFE)

Luminex (NASDAQ: LMNX)

Miltenyi Biotech

MWG Biotech

OligoEngine

Open Biosystems

OriGene

OZ Biosciences

Promega

Qiagen (NasdaqGS: QGEN)

Santa Cruz Biotechnology

Sigma-Aldrich (NASDAQ: SIAL)

System Biosciences

Exploring Structural Biology:  Tools & Techniques Used in the Study of Membrane Protein Structure (#10-004)Due out at the end of October, this study was designed to provide membrane structural biology product suppliers with critical insights as to technologies and areas of research with the highest potential for rapid growth. Recent technological advancements and the introduction of computational approaches to the analysis of membrane components have brought new life to membrane structural biology, and this report provides a roadmap for suppliers who seek to explore new market opportunities.

Scientists provide insights as to planned instrument and consumable purchases by vendor.  The following suppliers were provided as some of the choices in the survey:

Abcam

Active Motif

Agilent Technologies (NYSE: A)

Amersham Biosciences (GE Healthcare)

Anasazi Instruments

Bio-Rad (NYSE: BIO)

BioVision

Bruker (NASDAQ: BRKR)

Buchi

Clontech

Dionex (NASDAQ: DNEX)

EMD Millipore

Fermentas Life Sciences

Flowgen Bioscience

GE Healthcare (NYSE: GE)

Hitachi (NYSE: HIT)

Imgenex

JASCO

JEOL

Life Technologies (NasdaqGS: LIFE)

Miltenyi Biotec

New England Biolabs

PerkinElmer (NYSE: PKI)

Promega

Qiagen (NasdaqGS: QGEN)

Shimadzu (Tokyo: 7701)

Sigma-Aldrich (NASDAQ: SIAL)

Teledyne Isco (NYSE: TDY)

Thermo Fisher Scientific (NYSE:  TMO)

Varian

Wang NMR

Waters Corporation (NYSE: WAT)

Genomic Technologies:  Market Insights for Life Science Suppliers (#10-005)This report is for life science suppliers who want to respond in a timely fashion to the rapidly changing market for genomic analysis products. In this study, BioInformatics LLC quantifies and characterizes the market for genetic analysis including those products used for genome-wide association studies (GWAS), copy number variation (CNV) analysis, genotyping and techniques such as microarrays, sequencing and real-time PCR.

Delivery is scheduled for mid-November.

Survey respondents indicate planned lab expenditures by vendor.  The following suppliers were provided as some of the choices in the survey:

Agilent Technologies (NYSE: A)

Affymetrix (NASDAQ: AFFX)

Beckman Coulter (NYSE: BEC)

BD Biosciences (NYSE: BDX)

Bioneer

Bio-Rad (NYSE: BIO)

BioTrove

Cepheid (NASDAQ: CPHD)

Eppendorf

GE Healthcare (NYSE: GE)

Helicos Bioscience (NASDAQ: HLCS)

Idaho Technology, Inc.

Illumina (NASDAQ: ILMN)

Li-Cor Biosciences

Life Technologies (NasdaqGS: LIFE)

Luminex (NASDAQ: LMNX)

Qiagen (NasdaqGS: QGEN)

Roche Applied Science

Sequenom (NASDAQ: SQNM)

Stratagene

Techne (NASDAQ: TECH)

 "RNAi, genomics and membrane protein structures are three fast-growing markets in the life science industry," states Tamara Zemlo, Ph.D., MPH, Vice President of Advisory Services.  Dr. Zemlo adds that "Suppliers are challenged to keep up with the ever-changing demands of researchers involved in this type of cutting edge research."

To learn more about these reports, complimentary Executive Summaries are available at

http://www.gene2drug.com/reports/210/

http://www.gene2drug.com/reports/208/

http://www.gene2drug.com/reports/209/

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry.  By leveraging our professional social network of more than 50,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions.  Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=50555 For more information contact:Mary FollinManager, Marketing/SalesBioInformatics, LLC2111 Wilson Blvd., Suite 250Arlington, VA  22201703.778.3080 x13 (phone)m.follin@gene2drug.com

http://www.gene2drug.com/
'/>"/>

SOURCE BioInformatics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010
2. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
3. Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth
4. Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012
5. Reportlinker Adds European RIS/PACS Market
6. Reportlinker Adds U.S. Venous Access Catheter Market
7. Reportlinker Adds Pharmaceutical Contract Manufacturing: Industry and Market Prospects 2010-2025
8. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
9. Creating Partnerships Across R&D and Marketing to Ensure a Successful Global Launch
10. Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Womens Health Market
11. Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a ... cells and other difficult to transfect cells, announces its launch of the PluriQ™ ... Gene Editing System is a complete system for culturing and transfecting human ...
Breaking Medicine News(10 mins):